NPCENeuroPace, Inc.

$482M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+61.9% YoY

Gross Profit

$12M72.5% margin

Operating Income

-$8M-47.6% margin

Net Income

-$9M-55.3% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$102M

Total Liabilities

$81M

Stockholders' Equity

$21M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$10M	+61.9%
Gross Profit	$12M	$7M	+60.4%
Operating Income	-$8M	-$11M	+28.4%
Net Income	-$9M	-$13M	+28.1%

NPCE Q2 2023 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena